Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Vildagliptin Carboxylic Acid | C17H26N2O4 | 565453-40-9 | Details |
| Vildagliptin Carboxylic Acid Methyl Ester | C18H28N2O4 | 948574-56-9 | Details |
| Vildagliptin Impurity ZA6 | C17H23N3O2 | 2246354-69-6 | Details |
| Vildagliptin Impurity 18 | C7H10ClNO3 | 23500-10-9 | Details |
| vildagliptin Impurity Isomer | C17H25N3O2 | 1036959-27-9 | Details |
| Vildagliptin iMpurity K | C17H27N3O3 | 565453-39-6 | Details |
| (2S)-1-(2,2,2-trifluoroacetyl)pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-(trifluoroacetyl)-, (S)- (9CI) | C7H7F3N2O | 151258-26-3 | Details |
| vildagliptin Impurity V | C12H19NO3 | 1032564-18-3 | Details |
| Linagliptin impurity 16 | C26H29N9O3 | 1955514-80-3 | Details |
| Vildagliptin Related Compound A | C17H25N3O | 741657-02-3 | Details |
| vildagliptin Impurity U | C8H12ClNO3 | 38074-72-5 | Details |
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]- | C21H21N7O2 | 2468656-63-3 | Details |
| Vildagliptin Impurity | C19H27F3N2O6 | 565453-41-0 | Details |
| Vildagliptin Impurity 13 | C6H11NO2 | 2577-48-2 | Details |
| C24H32N6O4 | 2518331-40-1 | Details |
| Linagliptin Impurity F | C27H27F3N8O3 | 1673546-62-7 | Details |
| Linagliptin iMpurity E | C25H28N8O2 | 1446263-38-2 | Details |
| Linagliptin Impurity 35 | C30H36N8O4 | 668273-75-4 | Details |
| Linagliptin Impurity 14 | C25H29N7O4 | 2416949-69-2 | Details |
| yl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamoyl]benzoicacid | C33H32N8O5 | 2074688-81-4 | Details |
| Linagliptin N-Acetyl Impurity | C27H30N8O3 | 1803079-49-3 | Details |
| Linagliptin Impurity 33 | C38H42N10O4 | 2443735-53-1 | Details |
| Linagliptin Impurity 3 | C19H24N6O2 | 2749409-37-6 | Details |
| Linagliptin iMpurity G | C25H28N8O2 | 668270-11-9 | Details |
| Linagliptin Impurity K | C25H29BrN8O2 | 1638744-06-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C21H24N8O2 | 2748491-45-2 | Details |
| Linagliptin Impurity D | C20H28N6O4 | 666816-91-7 | Details |
| C26H28N8O3 | 2137744-33-1 | Details |
| 2-QuinazolineMethanol, 4-Methyl- | C10H10N2O | 13535-91-6 | Details |
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]- | C30H26N8O3 | 2469626-53-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C16H13BrN6O2 | 2749405-42-1 | Details |
| (R)-1-Boc-3-Aminopiperidine | C10H20N2O2 | 625471-18-3 | Details |
| Linagliptin Impurity S | C30H36N8O4 | 668273-74-3 | Details |
| Linagliptin Impurity 51 | C26H21BrN8O2 | 2138392-83-1 | Details |
| tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate | C20H28N4O2 | 2514949-81-4 | Details |
| Linagliptin Impurity 24 | C50H56N16O4 | 1418133-47-7 | Details |
| Linagliptin Impurity 16 | C15H20N6O2 | 1791405-13-4 | Details |
| Linagliptin Impurity 29 | C58H58N16O6 | 2074688-82-5 | Details |
| Etoricoxib Impurity 9 | C13H17NO3S2 | 859824-65-0 | Details |
| Linagliptin impurity KH-3 | C30H37N7O6 | 2279114-27-9 | Details |
| Acetamide, N-(2-acetylphenyl)-2,2-dichloro- | C10H9Cl2NO2 | 6140-12-1 | Details |
| Etoricoxib Impurity 8 | C22H20N2O4S | 1421227-97-5 | Details |
| Etoricoxib Impurity 13 | C25H20ClN3O3S | 1817735-82-2 | Details |
| N-Phthalimide-linagliptin | C33H30N8O4 | 886588-63-2 | Details |
| INDEX NAME NOT YET ASSIGNED | C26H32N8O4 | 2748381-67-9 | Details |
| Etoricoxib Impurity 11 | C17H13ClN2O2S | 202409-31-2 | Details |
| C10H20N2O2 | 216854-23-8 | Details |
| 5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide | C18H15ClN2O3S | 325855-74-1 | Details |
| 6'-DesMethyl-6'-carboxy Etoricoxib | C18H13ClN2O4S | 349536-39-6 | Details |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | C20H17BrN6O2 | 853029-57-9 | Details |
| 6'-DesMethyl-6'-Methylhydroxy Etoricoxib | C18H15ClN2O3S | 349536-41-0 | Details |
| N-Depiperidin-3-amine Linagliptin Dimer | C45H44N14O4 | 2253964-98-4 | Details |
| 2 - (ChloracetylaMino)acetophenon | C10H10ClNO2 | 6140-11-0 | Details |
| Linagliptin Impurity H | C22H23N7O2 | 1646355-34-1 | Details |
| Linagliptin Impurity 10 | C20H18N6O2 | 1911621-52-7 | Details |
| Linagliptin Impurity A | C14H13BrN4O2 | 2436762-89-7 | Details |
| Etoricoxib Impurity 47 | C18H15NO4S | 2241145-66-2 | Details |
| Linagliptin Impurity 45 | C25H28N8O2 | 2463617-43-6 | Details |
| Linagliptin impurity | C34H34N8O5 | 2444011-29-2 | Details |
| Linagliptin Impurity 28 | C22H23N7O3 | 2074688-84-7 | Details |
| Linagliptin Impurity 20 | C51H56N16O4 | 2463617-49-2 | Details |
| Linagliptin impurity KH-2 | C20H18BrN5O4 | 2279114-31-5 | Details |
| Olmesartan Medoxomil Impurity F | C48H42N6O5 | 1227626-51-8 | Details |
| (Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime | C15H16N2O3S | 1810761-43-3 | Details |
| Olmesartan Impurity 1 | C11H18N2O2 | 2411637-68-6 | Details |
| Etoricoxib Impurity H | C20H21N3O2S | 646459-39-4 | Details |
| Olmesartan Impurity 19 | C14H11ClN4 | 161952-66-5 | Details |
| 5-[4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl]-2-(triphenylmethyl)-2H-tetrazole | C33H25BrN4 | 133051-88-4 | Details |
| 4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile | C14H9Br2N | 209911-63-7 | Details |
| Dehydro Olmesartan | C24H24N6O2 | 172875-98-8 | Details |
| Etoricoxib Impurity O | C15H15NO2S | 307531-95-9 | Details |
| Olmesartan Medoxomil Impurity O | C45H44N6O3 | 189400-21-3 | Details |
| Olmesartan Medoxomil EP Impurity C | C29H28N6O5 | 879562-26-2 | Details |
| Olmesartan Medoxomil Methyl Ether | C30H32N6O6 | 896419-17-3 | Details |
| Etoricoxib impurity Q | C18H15ClN2S | 292067-97-1 | Details |
| Olmesartan Impurity 51 | C45H46N6O2 | 1418133-29-5 | Details |
| Olmesartan Impurity G | C33H24Br2N4 | 358685-13-9 | Details |
| OlMesartan interMediate iMpurity II | C11H16N2O3 | 144690-07-3 | Details |
| Olmesartan Medoxomil EP Impurity D | C48H44N6O6 | 1020157-01-0 | Details |
| Olmesartan Medoxomil Impurity 26 | C34H34N6O9 | 1392475-91-0 | Details |
| Olmesartan Medoxomil Impurity 17 | C53H54N12O8 | 1418133-31-9 | Details |
| 1H-Imidazole-4,5-dicarboxylic acid, 2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- | C41H34N6O4 | 1350442-05-5 | Details |
| OlMesartan Lactone IMpurity | C24H24N6O2 | 849206-43-5 | Details |
| 2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine | C17H15NO3S | 307531-96-0 | Details |
| Olmesartan Medoxomil Impurity 28 | C14H10Br2N4 | 1127249-17-5 | Details |
| Olmesartan Impurity 8 | C12H18N2O2 | 157356-73-5 | Details |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C15H20N2O6 | 144978-05-2 | Details |
| Etoricoxib Impurity 18 | C15H15NO4S | 1027162-35-1 | Details |
| Olmesartan Impurity 65 | C13H22N2O3 | 172875-53-5 | Details |
| Olmesartan Impurity 89 | C33H24Br2N4 | 151052-34-5 | Details |
| Etoricoxib Impurity 36 | C13H17NO4S | 1798110-01-6 | Details |
| Etoricoxib Impurity | C18H15ClN2O4S | 2724840-93-9 | Details |
| 4-(hidroximetil)-5-metil-1,3-dioxol-2-one | C5H6O4 | 91526-18-0 | Details |
| OlMesartan DiMer Ester IMpurity | C48H50N12O5 | 1040250-19-8 | Details |
| Olmesartan Medoxomil Impurity 7 | C43H40N6O3 | 761404-85-7 | Details |
| 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole | C14H11BrN4 | 138402-33-2 | Details |
| Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
| Trityl olmesartan | C48H44N6O6 | 144690-92-6 | Details |
| Olmesartan Medoxomil Impurity G | C43H38N6O2 | 761404-82-4 | Details |
| Olmesartan Impurity 38 | C46H46N6O3 | 1039762-39-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||